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Objectives: Epidemiological studies indicate that first- and second-hand cigarette smoke (CS) exposure are important risk factors for the
development of type 2 diabetes (T2D). Additionally, elevated diabetes risk has been reported to occur within a short period of time after smoking
cessation, and health risks associated with smoking are increased when combined with obesity. At present, the mechanisms underlying these
associations remain incompletely understood. The objective of this study was to test the impact of CS exposure on pancreatic b-cell function
using rodent and invitromodels.
Methods: Beginning at 8 weeks of age, C57BL/6 J mice were concurrently fed a high-fatdiet (HFD) and exposed to CS for 11 weeks, followed by
an additional 11 weeks of smoking cessation with continued HFD. Glucose tolerance testing was performed during CS exposure and during the
cessation period. Cultured INS-1 b-cells and primary islets were exposed ex vivo to CS extract (CSE), and b-cell function and viability were tested.
Since CS increases ceramide accumulation in the lung and these bioactive sphingolipids have been implicated in pancreatic b-cell dysfunction in
diabetes, islet and b-cell sphingolipid levels were measured in islets from CS-exposed mice and in CSE-treated islets and INS-1 cells using liquid
chromatography-tandem mass spectrometry.
Results: Compared to HFD-fed, ambient air-exposed mice, HFD-fed and CS-exposed mice had reduced weight gain and better glucose tolerance
during the active smoking period. Following smoking cessation, CS-mice exhibited rapid weight gain and had accelerated worsening of their
glucose tolerance. CS-exposed mice had higher serum proinsulin/insulin ratios, indicative of b-cell dysfunction, significantly lower b-cell mass
(p ¼ 0.017), reduced b-cell proliferation (p ¼ 0.006), and increased islet ceramide content compared to non-smoking control mice. Ex vivo
exposure of isolated islets to CSE was sufficient to increase islet ceramide levels, which was correlated with reduced insulin gene expression and
glucose-stimulated insulin secretion, and increased b-cell oxidative and endoplasmic reticulum (ER) stress. Treatment with the antioxidant N-
acetylcysteine markedly attenuated the effects of CSE on ceramide levels, restored b-cell function and survival, and increased cyclin D2
expression, while also reducing activation of b-cell ER and oxidative stress.
Conclusions: Our results indicate that CS exposure leads to impaired insulin production, processing, secretion and reduced b-cell viability and
proliferation. These effects were linked to increased b-cell oxidative and ER stress and ceramide accumulation. Mice fed HFD continued to
experience detrimental effects of CS exposure even during smoking cessation. Elucidation of the mechanisms by which CS exposure impairs
b-cell function in synergy with obesity will help design therapeutic and preventive interventions for both active and former smokers.
 2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords Ceramide; Smoking; Insulin secretion; Oxidative stress; b-cell; Type 2 diabetes1Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA 2Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville,
TN, USA 3Indiana Bioscience Research Institute, Indianapolis, IN, USA 4Division of Pulmonary and Critical Care Medicine, Department of Medicine, National Jewish Health,
Denver, CO, USA 5Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA 6Department of Cellular and Integrative Physiology, Indiana University School of Medicine,
Indianapolis, IN, USA 7Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA 8Herman B Wells Center for Pediatric
Research, Indiana University School of Medicine, Indianapolis, IN, USA
9 These authors contributed equally to this work.
*Corresponding author. Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN, 46202, USA. Tel.: þ317 274 4145; fax 317 274 4107. E-
mail: konot@iu.edu (T. Kono).
***Corresponding author. Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. E-mail: cevansmo@iu.edu (C. Evans-Molina).
**Corresponding author. 1400 Jackson St, Denver, CO, 80806, USA. Tel.: þ303 270 2080. E-mail: PetracheI@NJHealth.org (I. Petrache).
Received August 29, 2019  Revision received March 3, 2020  Accepted March 6, 2020  Available online 13 March 2020
https://doi.org/10.1016/j.molmet.2020.100975




ASAH1 N-acylsphingosine amidohydrolase 1
AUC Area under the curve
BiP/GRP78/HSPA5 Binding immunoglobulin protein, Glucose
regulated protein 78kD, Heat-Shock
70kD protein 5
CHOP CCAAT/enhancer-binding protein homologous protein
CS Cigarette smoke
CSE Cigarette smoke extract
DH-Ceramide dihydroceramide
ER endoplasmic reticulum
FCCP Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone
GPX1 Glutathione Peroxidase 1
GTT Glucose tolerance test
HFD High-fat diet
Hsp30 Heat-Shock protein 30 kD
ITT Insulin tolerance test
LC-MS/MS Liquid chromatography-tandem mass spectrometry
NAC n-acetylcysteine
NS Non-smoking control
Nrf2 Nuclear factor erythroid 2erelated factor 2
OCR Oxygen consumption rate
PC1/3 Proprotein convertase 1/3
p21 cyclin-dependent kinase inhibitor p21
S1P sphingosine-1-phosphate
SPT1 serine palmitoyltransferase 1
SMPD sphingomyelin phosphodiesterase
SPHK Sphingosine Kinase
SOD1 Superoxide dismutase 1
UGCG Ceramide glucosyltransferase
T2D Type 2 diabetes
Xbp-1 X-box binding protein 1
Original Article1. INTRODUCTION
Worldwide, diabetes and cigarette smoking are highly prevalent public
health concerns. Type 2 diabetes (T2D) impacts over 422 million in-
dividuals, and more than 1.1 billion individuals actively smoke [1,2].
More strikingly, nearly 1.9 billion individuals are exposed second hand
to cigarette smoke (CS) [3]. While a number of genetic risk variants for
T2D have been identified through genome wide association studies,
lifestyle factors such as nutrition, physical activity, and potential
chemical and environmental exposures are thought to strongly influ-
ence diabetes susceptibility. Epidemiological studies indicate that CS
exposure is an important risk factor for the development of T2D, and
diabetes risk remains heightened even after smoking cessation [4,5].
Thus, first and second hand smoke exposure represent important
modifiable risk factors for the development of T2D in a potentially large
pool of at-risk individuals [6,7].
Human physiologic studies suggest that CS exposure impairs periph-
eral insulin sensitivity and pancreatic b-cell function, despite a link to
reduced body weight [8e10]. In addition, individual cohort studies
have shown that within 1e5 years after smoking cessation, subjects
with a previous smoking history had a 22e91% higher incidence of
developing T2D [11,12], and this increased risk was correlated to
weight gain after cessation of tobacco use [13]. At present, the
mechanisms underlying impaired glucose homeostasis in response to
cigarette smoke exposure, especially a full understanding of the effects
of smoking on pancreatic b-cell function, remain unknown.
To address this knowledge gap, we developed a rodent model of CS
exposure coupled with a high-fat diet (HFD) to mimic the combined
effects of CS and diet-induced obesity. To provide insight into the
mechanisms of smoking induced b-cell dysfunction, analysis of this
rodent model was combined with an in vitro model where cultured
b-cells and primary rodent islets were exposed to CS extract (CSE).
Exposure to CSE, derived from smoke condensate followed by removal
of particulate matter, has been extensively used in ex vivo models
[14e18]. Previous studies have reported a significant increase in
ceramide in the lung and other tissues after experimental exposure to
CS [18e20], so we also tested whether CS-exposure influenced b-cell
ceramide content. In our in vivo model, the combination of CS exposure
and HFD caused rapid weight gain in mice and increased b-cell cer-
amide levels during the immediate cessation period. Smoking-induced2 MOLECULAR METABOLISM 37 (2020) 100975  2020 The Authors. Published by Elsevier GmbH. Tceramide accumulation in b-cells was correlated with impaired b-cell
function, reduced b-cell mass and proliferation, and impaired insulin
secretion and processing. These effects were largely recapitulated in
our in vitro model of CSE-exposed b-cells and islets, where we
observed increased ceramide levels, reduced insulin secretion, and
reduced b-cell survival. The antioxidant NAC reversed the in vitro
effects of CSE exposure and prevented excessive ceramide accumu-
lation, suggesting a primary role for oxidative stress in smoking-
induced b-cell dysfunction.
2. MATERIALS AND METHODS
2.1. Animals and metabolic studies
Male C57BL/6 J mice were obtained from Jackson Laboratories (Bar
Harbor, ME) at 7 weeks of age and maintained under protocols
approved by the Indiana University School of Medicine Institutional
Animal Care and Use Committee in accordance with guidelines from
the Association for Assessment and Accreditation of Laboratory Animal
Care. Mice were fed a high-fatdiet (HFD) containing 45% of kilocalories
from fat (D12451, Research Diets Laboratories, New Brunswick, NJ),
beginning at 8 weeks of age and were maintained on a standard lighte
dark cycle with ad libitum access to HFD and water. In parallel with
HFD initiation, mice were exposed to CS using 3R4F research grade
cigarettes (Kentucky Tobacco Research and Development Center,
University of Kentucky, Lexington, KY), with 11% mainstream and 89%
side-stream smoke or ambient air control for 5 h a day, 5 days a week
for a total of 11 weeks, using the Teague 10 E whole body exposure
apparatus (Figure 1A) [21]. Intraperitoneal glucose tolerance tests
(GTT) were performed after 6 h of fasting followed by the adminis-
tration of glucose at a dose of 2 g/kg total body weight. Insulin
tolerance tests (ITT) were performed after 3 h of fasting and admin-
istration of recombinant human insulin from Boehringer Ingelheim
Vetmedica (Duluth, GA) at a dose of 0.75 IU/kg total body weight.
Glucose levels were measured using the AlphaTRAK glucometer
(Abbott Laboratories, Abbott Park, IL). Serum insulin and proinsulin
levels were measured using ELISAs from Mercodia (Salem, NC) and
ALPCO Diagnostics (Salem, NH), respectively. Dual X-ray Absorpti-
ometry (DEXA) analysis was performed to estimate body composition
using the Lunar PIXImus II (GE Medical Systems) as previously
described [22].his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1: CS exposure increased weight gain and worsened glucose tolerance after smoking cessation in HFD-fed C57BL/6J mice. (A) Schematic of study design.
Non-smoking (NS) and Cigarette Smoke (CS) groups were fed a high-fat diet (HFD) containing 45% of kilocalories from fat for 22 wks. CS mice were placed in a smoking chamber
for 5 h/day for 5 days per week for the first 11 weeks. NS mice were exposed to room air. After 11 weeks, both NS and CS groups continued for an additional 11 weeks on HFD
with standard housing conditions. (B) Results of weekly body weight measurements for 0e22 weeks of the study. (C) Body weight gain during the smoking and cessation periods.
(DeE) Body lean/fat mass and weights of whole pancreas, liver, and epididymal fat pads were compared between the groups at the end of the study. (F-G, J-K) Glucose tolerance
tests (GTT) and insulin tolerance tests (ITT) were performed during the smoking period (week 9e11) and the cession period (week 20e22). (H, L) Area Under Curve (AUC) for GTT
and ITT data was quantified. (I, M) Percentage (%) change of AUC during the cessation period (week 20e22 minus week 9e11/week 9e11) was analyzed for each group. Data for
individual animals are indicated by the open circles; n ¼ 8e15. Results are displayed as the means  S.E.M; *p < 0.05, **p < 0.01, ***p < 0.001 compared to non-smoking
group (NS) or indicated comparisons.2.2. Immunohistochemistry and immunofluorescence
Pancreata were rapidly removed following euthanasia and fixed
overnight using Z-fix buffered zinc formalin fixative (Anatech Ltd.,
Battle Creek, MI), followed by paraffin embedding and longitudinal
sectioning at 5 mm intervals, as previously described [22]. b-cell
proliferation was assessed as detailed in previous publications [23].
b-cell mass was estimated for each animal by determining the average
b-cell surface area multiplied by the pancreatic weight, as previously
described [23,24]. A total of 13 mice were analyzed for b-cell mass,
and 4e5 sections, at least 50 mm apart, per animal were stained and
analyzed using Zen Blue software (Carl Zeiss, Jena, Germany).
2.3. Glucose-stimulated insulin secretion (GSIS), quantitative real-
time PCR (qRT-PCR) and immunoblot
Mouse pancreatic islets were isolated by collagenase digestion, and
INS-1 832/13 rat insulinoma cells were cultured as previously
described [25]. Static GSIS, qRT-PCR, and immunoblot analysis were
performed using previously published methods [26]. Islet perifusion-
based secretory profiles was measured using the Biorep Perifusion
System (Biorep, Miami Lakes, FL). Twenty-four hours after isolation,
50 handpicked islets were loaded into each perifusion chamber; islets
were perifused with Krebs buffer containing 2.8 mmol/L glucose for
20 min, followed by 16.7 mmol/L glucose for 40 min at a rate of
120 mL/min. Secreted insulin was measured using ELISA (Mercodia);
results were normalized to total DNA content. The following primary
antibodies were employed at the indicated dilutions: anti-totalMOLECULAR METABOLISM 37 (2020) 100975  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.comcaspase-3 rabbit antibody, which detected both cleaved and total
caspase-3 (1:1000, Cell Signaling, Danvers, MA); anti-PC1/3 rabbit
antibody (1:1000, Cell Signaling); anti-Cyclin D2 rabbit antibody
(1:1000, Santa Cruz Biotechnology, Santa Cruz, CA), and anti-Actin
mouse antibody (1:10,000, MP Bioscience, Santa Ana, CA).
2.4. Cigarettes smoke extract (CSE) preparation and cell-based
studies
Aqueous CSE was obtained from research-grade cigarettes (3R4F)
purchased from the Kentucky Tobacco Research and Development
Center (University of Kentucky, Lexington, KY) as previously described
[18]. In brief, air control (AC) or CSE stock (100%) extract were pre-
pared by bubbling ambient air or smoke from two cigarettes into 20 ml
of PBS at a rate of 1 cigarette/minute, followed by pH adjustment to
7.4, and 0.2 mm filtration. Cell and islet treatments were performed
using CSE or AC extract concentrations ranging from 1% to 10%
(vol:vol). To adjust the variation of potency of CSE from different lots,
we performed titration tests for cell viability measuring ATP levels with
CellTiter-Glo Luminescent Cell Viability Assay (Promega, Madison, WI).
We determined a lethal concentration defined as 50% death after 24 h
treatment (LC50) and used this concentration for CSE treatment. For
propidium iodide (PI) staining, INS-1 cells were dissociated with
trypsineEDTA, followed by 70% ethanol fixation. Cells were then
washed with PBS and incubated at 37 C for 40 min in 50 mg/ml PI
solution. Imaging cytometry analysis was performed using the Cello-
meterTM K2 (Nexcelom Bioscience, Lawrence, MA). CellTiter-Gloccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 3
Original ArticleLuminescent Cell Viability Assay (Promega, Madison, WI) and Earlytox
live/dead assay kit (Molecular Devices, San Jose, CA) were used for
studies of INS-1 cells treated with CSE or AC extract with or without
5 mM N-Acetyl Cysteine (NAC) from Invitrogen; Thermo Fisher
Scientific, Inc (Waltham, MA) and tauroursodeoxycholic acid (TUDCA)
from Cayman Chemical (Ann Arbor, MI) coincubation for 24 h.
2.5. Analysis of sphingolipids by LC-MS/MS
To profile sphingolipids in isolated mouse islets or INS-1 cells, lipid
extraction and liquid chromatography-tandem mass spectrometry (LC-
MS/MS) were performed according to detailed methods published
previously [19]. The MS system was a Sciex 6500 QTRAP mass
spectrometer interfaced with a Shimadzu Nexiera X2 UHPLC system.
Sphingolipids were ionized via electrospray ionization (ESI) with
detection via multiple reaction monitoring (MRM). Analysis of sphingoid
bases and the molecular species of ceramides employed ESI in positive
ions with MRM analysis. C17-sphingosine and NeC17-ceramide were
used as the internal standards.
2.6. Analysis of mitochondrial respiration
The Seahorse Extracellular Flux Analyzer XFe96 (Agilent Technologies)
and Mito Stress Test (Agilent Technologies cat# 103,015) were utilized
to measure mitochondrial respiration in INS-1 cells treated with AC,
CSE or CSEþ NAC for 20 h. Cells were incubated in pre-warmed assay
media at a pH of 7.4 (Agilent Technologies 103,576e100) that had
supplemented with 11 mM glucose, 2 mM L-glutamine and 1 mM
pyruvate in a non-CO2 incubator at 37 C for 1 h prior to the assay.
Mito Stress Test assay compounds, Oligomycin (2.0 mM), FCCP
[Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone] (3.0 mM), and
Rotenone/Antimycin (1.0 mM) were diluted in assay media and
sequentially added to the cells atw15 min,w34 min, andw54 min,
respectively. Oxygen consumption readings were taken every 6.5 min
for a total of three readings prior to and after each injection of com-
pound. Oxygen consumption rates (OCR) were normalized by total cell
count per well. Cells in each well were counted using phase-contrast
and cell masking on the IncucyteS3 imaging platform using a 10
objective and autofocus capability.
2.7. Statistical analysis
Differences between groupswere analyzed for significance using unpaired
Student’s t test or one-way analysis of variance with TukeyeKramer
post hoc analysis. Results are displayed as the means  S.E.M. Data
were analyzed using GraphPad Prism software (GraphPad Software, La
Jolla, CA) and a p value < 0.05 was taken to indicate the presence of a
significant difference between experimental groups.
3. RESULTS
3.1. CS exposure followed by smoking cessation increased weight
gain and worsened glucose tolerance in mice
C57BL/6 J mice were exposed to an initial phase of 11 weeks of CS
exposure (for 5 h/day; 5 days per week) combined with 45% HFD,
which closely mimics a high-fat Western diet [27]. This was followed
by smoking cessation and continued HFD exposure for an additional 11
weeks (Fig. 1A). Control mice (NS) were maintained under normal
ambient air control conditions combined with a 45% HFD for the entire
22-week treatment period.
During the active smoking period, CS-exposed mice had reduced body
weight compared to the NS group, but their rate of weight gain
increased during the smoking cessation period (Figure 1BeC), such
that by the end of the 22-week experiment, total body weight (Fig. 1B),4 MOLECULAR METABOLISM 37 (2020) 100975  2020 The Authors. Published by Elsevier GmbH. Tlean mass, and fat mass (Fig. 1D) were similar between the groups.
Whole pancreas, liver, and epididymal fat weights were analyzed, and
only liver weights were significantly higher in the CS-exposed group at
week 22 (Figure 1DeE).
Concordant with the observed patterns of total body weight change,
glucose tolerance in CS-exposed mice at 11 weeks was better than
that of HFD-mice maintained under control air conditions. Although the
differences of absolute GTT responses between the groups at the end
of the 22-week observation period did not reach statistical significance
(Figure 1FeH), when analyzed as the % change in the area under the
curve (AUC) from 11 to 22 weeks, CS-exposed mice exhibited a
significantly higher % change during smoking cessation (Fig. 1I).
In addition, insulin sensitivity of the CS-exposed group was higher
during the smoking period, followed by marked worsening during the
smoking cessation period (Figure 1JeL). Similar to the glucose
tolerance trend, the CS group animals had a significantly higher %
change in the AUC of the ITT response from 11 to 22 weeks (Fig.1M).
3.2. CS reduced insulin processing, b-cell mass, and b-cell
proliferation during the smoking cessation period in C57BL/6 J mice
To define the origins of the failed adaptive response to HFD observed
during the smoking cessation period, we analyzed insulin processing
capacity, b-cell mass and b-cell proliferation in CS-exposed and NS
mice. Elevations in the serum proinsulin/insulin (PI/I) ratio are observed
in humans with both T1D and T2D and reflect a reduced ability to
complete processing of proinsulin to mature insulin arising within the
context of increased b-cell stress [4]. At 22 weeks, the PI/I ratio in
serum was increased in the CS-exposed group compared to NS
controls (Figure 2AeC). In addition, analysis of b-cell mass revealed a
significant reduction (3.00 mg vs. 2.21 mg, p ¼ 0.00167) in CS-
exposed mice (Figure 2DeE). Consistent with this finding, b-cell
proliferation, which was determined by quantification of proliferating
cell nuclear antigen (PCNA) and insulin co-staining, was reduced in
CS-exposed mice compared to control mice (p ¼ 0.006) (Fig. 2F).
3.3. CS exposure increased ceramide accumulation in pancreatic
islets during the smoking cessation period
Next, using tandem mass spectrometry, we measured ceramide levels
in isolated islets from mice exposed to CS before and following
smoking cessation. At week 11, CS exposure was associated with
modest reductions in ceramides compared to control mice, mostly in
palmitoyl (C16:0)- and behenic (C22:0)- ceramide species. In contrast,
islets from CS-exposed mice isolated at 16 weeks exhibited marked
increases in multiple species, including stearic (C18:0)-, arachidic
(C20:0)-, docosanoid-, and the saturated and monounsaturated
lignoceric (C24:0 and C24:1)- ceramides (Figure 3B).
3.4. CSE treatment increased ceramides and related metabolites in
INS-1 cells and isolated mouse islets
Islets could be directly affected by soluble components of CS that cross
the alveolar-capillary lung barrier and are distributed to tissues via the
circulation. Alternatively, they could be injured by mediators released
by other CS-activated cells in a paracrine or autocrine manner [28,29].
To determine whether direct CS exposure was itself sufficient to cause
islet dysfunction and increase ceramide levels, we exposed cultured b-
cells and mouse islets to CSE ex vivo. We used culture medium
containing 10% FBS, which contains w50 mM total free fatty acids
and 15 mM palmitate, capable of serving as precursors for de novo
ceramide synthesis. In both models, CSE exposure for 24 h resulted in
a marked increase in multiple ceramide species. Compared to control-
treated cells, CSE-treatment increased ceramides in INS-1 cellshis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: CS reduced insulin processing, b-cell mass, and b-cell proliferation during the smoking cessation period in C57BL/6J mice. Following the study design
depicted in Figure 1A, the capacity for insulin production was evaluated in NS and CS mice at the study endpoint of 22 weeks. (AeC) Blood was collected from random fed mice
and serum levels of insulin, proinsulin, and the ratios of proinsulin to insulin were determined by ELISA. (DeF) The mass of insulin positive cells and the number of proliferating
b-cells within pancreata of study mice were quantified in paraffin tissue sections by immunostaining for insulin and the proliferative marker PCNA. Data for individual mice in each
group are indicated by the circles. Results are displayed as the means  S.E.M; *p < 0.05, **p < 0.01 compared to non-smoking (NS) group.ranging from w1.4 fold (palmitoyl- and stearic-ceramides) to more
than 1.7-fold (behenic- and lignoceric-ceramides) (Figure 4A).
Ceramides were increased to an even greater extent in CSE-exposed
islets, with most species being increased by more than 3-fold
compared to control conditions (Figure 4AeD). Mass spectrometric
measurements of other related sphingolipid metabolites revealed in-
creases in both precursors of ceramide in the de novo sphingolipid
synthesis pathway (DH-sphingosine and DH-ceramide (Figure 4BeD)
and, in the case of isolated islets, sphingosine (Fig. 4D), which is an
immediate downstream ceramide metabolite produced by ceramidase.
3.5. Exposure to CSE reduced insulin secretion and increased
activation of b-cell ER stress and oxidative stress signaling
pathways
Results from our in vivo model showed that serum insulin levels were
lower in mice exposed to CS. To test directly the impact of CSE onFigure 3: CS exposure increased ceramide accumulation in pancreatic islets follow
islets were isolated during the last week of the smoking period (A) and 5 weeks after smok
by LC-MS/MS and are shown as relative levels. Each sample has a total 200 islets pooled
circles and the number of replicated animals in each group was n ¼ 3e4 (6e8 mice). R
compared to the non-smoking group (NS) group.
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glucose-stimulated insulin secretion (GSIS) assays were performed in
INS-1 cells exposed to CSE for 24 h. GSIS was significantly reduced
(284.5 vs 115.2 mU/ml/mg protein, p ¼ 0.005) in CSE-exposed INS-1
cells versus control cells (Figure 5A). In addition, mature and pre-insulin
mRNA levels were reduced by 70.1% and 68.7%, respectively, in CSE-
exposed cells (Figure 5BeD), indicating a defect in insulin gene tran-
scription as well as a reduction in total levels of mature insulin mRNA.
Because both elevations in the proinsulin/insulin ratio, reduced insulin
expression, and ceramides have been linked with activation of b-cell
oxidative stress and ER stress [18], we next quantified the expression of
genes involved in these processes. Results from this analysis indicated
a global increase in the expression of genes involved in oxidative stress
(Nrf2, Sod1, and Gpx1) and ER stress signaling (Bip, CHOP, Hsp30, and
spliced/total Xbp-1) (Figure 5GeH). Consistent with these findings, live/
dead analysis showed that b-cell survival was reduced by w41.5%ing smoking cessation. The study design of Figure 1A was executed and pancreatic
ing cessation (B). The concentrations of six different ceramide species were determined
from two mice. The replicates for each experimental group are indicated by the open
esults are displayed as the means  S.E.M; *p < 0.05, **p < 0.01, ***p < 0.001,
ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 5
Figure 4: CSE treatment altered ceramide levels in INS-1 cells and isolated mouse islets. Cells and isolated mouse islets were incubated for 24 h with cigarette smoke
extract (CSE) or air control (AC) extract that were prepared by bubbling ambient air or smoke at a rate of 1 cigarette/minute. (A and C) The concentrations of six different ceramides
species were determined by LC-MS/MS. (B and D) Summary of LC-MS/MS results for total ceramide, dihydro (DH)-ceramide, C (18:0)-spingosince, and C (18:0) dihydro
(DH)-sphingosine. The replicates of cell samples and islets samples are indicated by open circles. For cells, n ¼ 5e6. For islets, each sample was prepared from a total of 200
islets pooled from two mice, with a total of eight individual mice per group. Results are displayed as the means  S.E.M; *p < 0.05, **p < 0.01, ***p < 0.001, compared to AC
group.
Figure 5: Exposure to CSE reduced insulin secretion and increased activation of b-cell ER stress and oxidative stress. Cells were incubated for 24 h with cigarette smoke
extract (CSE) or air control (AC) extracts as in Figure 4. (A) Glucose-stimulated insulin secretion into the supernatant was measured by ELISA and results were normalized to cellular
protein levels. (BeC) RNA was isolated from treated INS-1 cells and insulin transcript levels were determined by qRT-PCR. (D) Cellular insulin levels were determined by ELISA with
normalization of values to total protein levels. (E) Cell viability was determined by live/dead assay, and results are presented as the ratio of live to dead cells. (F) Immunoblotting was
performed using caspase-3 and actin antibodies in control and CSE treated cells. Results were normalized with actin expression levels. (G) Cells were incubated for 6 h with CSE or
AC extracts and gene expression of the oxidative stress markers Nrf2, Sod1 and Gpx1 were determined by qRT-PCR. Results were normalized with Actb expression levels. (H) Cells
were incubated for 24 h with CSE or AC extracts. Expression of the ER stress marker genes, Bip, Chop, Hsp90, and spliced Xbp-1 ratio were analyzed as described in (G). The
number of replicate samples for each analysis is indicated by the open circles; n ¼ 3e6. Results are displayed as the means  S.E.M; *p < 0.05, **p < 0.01, ***p < 0.001
compared to the AC group.
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following CSE exposure, while immunoblot analysis revealed a signif-
icant increase in cleaved caspase-3 expression in CSE-exposed b-cells
(Figure 5EeF). Taken together, these results suggest that CSE expo-
sure is able to directly induce ceramide accumulation in islets and b-
cells, which was linked with reduced insulin secretion, impaired b-cell
survival, and b-cell ER and oxidative stress.
3.6. Antioxidant treatment prevented CSE-induced loss of b-cell
function and viability
To test whether approaches aimed at inhibiting ceramide synthesis
might be able to prevent CSE-induced effects on b-cell viability, we
tested the effect of multiple chemical ceramide synthesis inhibitors in
CSE-treated INS-1 cells. We found no significant improvement in b-cell
viability with either 4 mM Fumonisin B1, 5 mM GW4869, or 25 mM
Imipramine (Supplemental Figs. S1AeC). Consistent with this finding,
mRNA expression of enzymes involved in ceramide synthesis path-
ways, including serine palmitoyltransferase 1 (SPT1), sphingomyelin
phosphodiesterase 1 (SMPD1) and 2 (SMPD2) were unchanged in
CSE-exposed INS1 cells (Supplemental Fig. S2) and significantly
reduced in mouse islets (Supplemental Fig. S3A). In addition, immu-
noblot analysis revealed downregulation of SPT1 protein by CSE in
mouse islets (Supplemental Fig. S3C). Interestingly, we observed
reduced expression of amidohydrolase 1 (ASAH1) and sphingosineki-
nase 2 (SPHK2) in CSE-treated islets, suggesting the possibility of
decreased catabolism/utilization of ceramides by CS (Supplemental
Fig. S3B).
Next, we tested whether the reversal of either oxidative or ER stress
could prevent CSE-induced b-cell dysfunction in experiments that
utilized the antioxidant n-acetylcysteine (NAC: 5 mM) or the chemical
chaperone tauroursodeoxycholic acid (TUDCA: 100 mM). The antioxi-
dant effect of NAC was confirmed by its inhibitory effect on CSE-
induced upregulation of Nrf2, a master transcriptional regulator of
the cellular antioxidant response (Figure 6A). As expected, TUDCA
prevented CSE-induced upregulation of ER stress markers without
significantly inhibiting CS-induced upregulation of oxidative stress
markers (Fig. 6B). Interestingly, ER stress was suppressed not only by
TUDCA but also by NAC treatment, suggesting that CSE-induced ER
stress may be linked to the induction of oxidative stress.
Treatment with NAC, but not with TUDCA, attenuated the effects of CSE
on GSIS in INS-1 cells, suggesting a dominant role for oxidative stress
in CSE-induced b-cell dysfunction (Fig. 6C). To further characterize the
impact of NAC on phasic insulin secretion in CSE-treated mouse islets,
perifusion experiments were performed. Here, CSE-treatment led to a
marked reduction in first phase insulin release, while insulin secretion
was significantly restored upon NAC treatment (Figure 6DeF). Similar
to effects observed on insulin secretion, NAC treatment inhibited CSE-
induced changes in b-cell viability as measured by live/dead assays
(Fig. 6G). Moreover, NAC but not TUDCA reduced caspase-3 cleavage
(Figure 6HeI).
Finally, considering the critical role that prohormone convertases play
in proinsulin processing, we measured expression levels of PC1/3 in
our in vitro model. Our results showed robust (21%) down-regulation of
the active form [30] (66 kD) of PC1/3 by CSE. In addition, NAC, but not
TUDCA treatment, was able to restore PC1/3 expression in CSE-treated
INS-1 cells (Fig.6J).
3.7. Antioxidant treatment prevented the effects of CSE on
sphingolipid accumulation in isolated mouse islets and restored
mitochondrial respiratory function in CSE-treated INS-1 cells
Since our data suggested that antioxidant treatment, rather than se-
lective prevention of ER stress, was necessary to mitigate the effects ofMOLECULAR METABOLISM 37 (2020) 100975  2020 The Authors. Published by Elsevier GmbH. This is an open a
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CSE-induced changes in islet ceramide levels. Isolated mouse islets
co-treated with NAC (5 mM, 24 h) and CSE showed a>55% reduction
in ceramide levels (Figure 7AeB), with changes observed across all
ceramide species (P < 0.05). Notably, the increase of the pro-
apoptotic ceramide metabolite, hydroxy-ceramide [31] induced by
CSE was markedly decreased by NAC (Fig. 7B). These data indicated
that more than half of the excessive sphingolipid accumulation induced
by CSE was oxidative stress-dependent.
To test whether alterations in mitochondria function contributed to the
CSE-induced dysfunction of b-cells as previously described [32], we
conducted analysis of mitochondria respiration using a Seahorse
Extracellular Flux Analyzer. Oxygen Consumption Rates (OCR) were
measured under basal conditions followed by the sequential addition of
oligomycin (2.0 mM), FCCP (3.0 mM), rotenone/antimycin (1.0 mM),
which resulted in significant alteration of OCR (Figure 7CeD). CSE
treatment significantly reduced the basal respiration (reduced by
68.0%, p < 0.0001), maximal respiration (reduced by 64%,
p < 0.0001), proton leak (reduced by 65%, p < 0.0001), and ATP
production (reduced by 66%, p < 0.0001), respectively (Fig. 7E).
Notably, all of the changes in mitochondrial function induced by CSE
were significantly reversed by antioxidant NAC treatment (Fig. 7E).
3.8. CS down-regulated CyclinD2 and impaired cell proliferation in
pancreatic islets
To further understand how CS exposure reduced b-cell mass and
proliferation, we interrogated cell cycle status in INS-1 cells after 24 h
exposure to CSE. CSE reduced cell proliferation, which was charac-
terized by an increased percentage of cells in the G0/G1 phase (39.2%
vs. 47.7%; p < 0.05) and a decreased percentage of cells in the G2/M
phase (45.3% vs. 37.4%; p< 0.05) (Figure 8A). qRT-PCR analysis of a
broad panel of cell cycle regulators revealed decreased cyclin D2
mRNA levels, while cyclin D1, and E1 mRNA levels were increased in
CSE-treated cells (Fig.8B). Immunoblot analysis in INS-1 cells treated
with CSE for 24 h showed a significant decrease in cyclin D2 protein
expression (Fig.8C). Consistent with this result, CSE reduced cyclin D2
mRNA levels in isolated mouse islets (Fig.8D). To determine the
relevance of these findings in our in vivo smoking model, immuno-
staining of cyclin D2 was performed in pancreatic sections collected
from CS and NS-exposed mice at the 22-week timepoint. CS-exposed
mice exhibited significant reductions in cyclin D2 expression within
islets, supporting the notion that b-cell proliferation was reduced via
the loss of this critical cell cycle regulator (Fig. 8E).
Finally, we tested a role for oxidative stress in cell-cycle regulation in
our CSE-model. Treatment with NAC significantly attenuated the
changes in cyclin D2 expression induced by CSE exposure (Figure 8Fe
G), suggesting an important role for oxidative stress in cell cycle
regulation. Using the same treatment conditions, we determined
expression levels of cyclin-dependent kinase inhibitor p21, which is a
known negative regulator of cyclin D2 [33]. Realtime qPCR analysis
revealed a significant increase in p21 expression in response to CSE
treatment, which was prevented by NAC (Fig. 8H). Together, these
results suggested that b-cell proliferation was reduced due to oxidative
stress via the upregulation of p21 coupled with a reduction in cyclin D2
(Fig.8I).
4. DISCUSSION
Despite an abundance of epidemiological data that links tobacco
smoking with an increased risk of diabetes, little is known regarding
the mechanisms underlying these associations. We aimed to addressccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 7
Figure 6: Antioxidant treatment prevented CSE-induced loss of b-cell function and viability. INS-1 cells were co-incubated with N-acetylcysteine (NAC: 5 mM) or the
chemical chaperone TUDCA (TUD: 100 mM) and cigarette smoke extract (CSE) for 24 h prior to assessment of indices of b-cell function. (AeB) RNA was isolated from treated INS-1
cells and gene expression of the oxidative stress marker Nrf2 and ER stress markers, Bip, Chop, Hsp90, and spliced Xbp-1 ratios were determined by qRT-PCR. (C) Glucose-
stimulated insulin secretion into the supernatant was measured by ELISA, and results were normalized to cellular protein levels. (DeF) Mouse islets were treated with CSE
for 24 h and loaded into perifusion chambers and then perfused with Krebs buffer containing 2.8 mmol/L glucose for 20 min, followed by 16.7 mmol/L glucose for 40 min at a rate
of 120 mL/min. Secreted insulin was measured using ELISA, and the results were normalized to total DNA content. (GeI) Total protein was isolated from treated cells and
immunoblotting was performed using antibodies recognizing caspase-3, Cyclin D2, proprotein convertase and actin. Results were normalized to actin levels. (J) Cell viability was
determined by a live/dead assay, and results expressed as the ratio of live to dead cells. The numbers of replicates for each measurement are indicated by the open circles,
n ¼ 3e4. Results are displayed as the means  S.E.M; *p < 0.05, **p < 0.01, ***p < 0.001 for indicated comparisons.
Original Articlethis knowledge gap by using a murine in vivo model of chronic CS
exposure combined with HFD. Data from our in vivo model was
complemented by analysis of an in vitro model of acute CS exposure
using INS-1 cells and isolated islets exposed to soluble components of
CS. To the best of our knowledge, this is the first study to investigate
the mechanisms by which CS impacts b-cell health and function.
Notably, we included in our experimental design assessments of the
direct effects of CS measured during a relatively chronic period of CS
exposure, as well as the effects of CS that were sustained following an
equal period of CS cessation. Extrapolating lifespans of mice to
humans, these timeframes have been linked with metabolic
dysfunction and diabetes risk. In persons with and without diabetes,
cigarette smoking is independently associated with higher hemoglobin
A1c (HbA1c) concentrations [34], and diabetes risk increases in a
dose-dependent manner with the number of cigarettes smoked per
day [35]. Interestingly, the risk of diabetes is also heightened in those
who have recently quit smoking, and this risk has been found to
correlate with weight gain following cessation. Therefore the mouse
model used in our studies is highly relevant to exploring the8 MOLECULAR METABOLISM 37 (2020) 100975  2020 The Authors. Published by Elsevier GmbH. Tmechanisms of human metabolic dysregulation that links CS, obesity,
and hyperglycemia.
As previously reported in CS-exposed mice fed regular chow [18], mice
in our study displayed reduced total body weight gain during CS
exposure, even when fed an HFD. This observation is consistent with
the known effects of CS to suppress appetite and increase energy
expenditure [20]. Glucose and insulin tolerance largely followed weight
patterns. During the active smoking period, CS-exposed mice were
more glucose tolerant and more insulin sensitive compared to HFD-fed
air control mice. In addition, GTT and ITTs were not different between
the smoking and non-smoking groups at the end of the 22-week
observation period. However, mice exposed to CS, who then under-
went smoking cessation, exhibited an accelerated body weight gain
with an associated rapid worsening of their glucose and insulin
tolerance. Interestingly, despite equivalent body weights between CS
exposed and control mice at treatment end, CS-exposed mice had
reduced b-cell mass and proliferation, reduced serum insulin levels,
and increased proinsulin/insulin ratios, suggesting that the chronic CS
exposure reduced the capacity for b-cell adaptation in the setting ofhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 7: Antioxidant treatment prevented the effect of CSE on lipid accumulation in isolated mouse islets and restored mitochondrial respiration in INS-1 cells
treated with CSE. Mouse islets were co-incubated with N-acetylcysteine (NAC: 5 mM) and cigarette smoke extract (CSE) for 24 h prior to analysis of lipid levels. (AeB) Summary
of LC-MS/MS results for total ceramide, dihydro (DH)-ceramide C (18:0)-spingosine, C (18:0) dihydro (DH)-sphingosine measurement, and hydroxy-ceramide. Each sample was
prepared from total 200 islets pooled from two mice, total 6e8 individual mice per group. (CeE) INS1 cells were co-incubated with N-acetylcysteine (NAC: 5 mM) and cigarette
smoke extract (CSE) for 20 h prior to analysis. Mitochondrial respiration was measured using the Seahorse Extracellular Flux Analyzer XFe96 and Cell Mito Stress Test Kit.
Schematic (C) and oxygen consumption rate (OCR) (D) assessed by extracellular flux analysis. OCR was measured under basal conditions followed by the sequential addition of
oligomycin (2.0 mM), FCCP (3.0 mM), rotenone/antimycin (1.0 mM). Each data point represents an OCR measurement. (E) Individual parameters for basal respiration, maximal
respiration, proton leak, and ATP production were normalized to cell count. The numbers of replicates for each experiment are indicated by the open circles, n ¼ 3e4. Results are
displayed as the means  S.E.M; *p < 0.05, **p < 0.01, ***p < 0.001 compared to AC, #p < 0.05, ##p < 0.01, ###p < 0.001 compared to CSE group.continued HFD exposure. Notably, these mice were also found to have
increased ceramide levels within their islets.
The lung, which is directly exposed via inhalation to the toxic effects of
tobacco smoking, exhibits a multitude of cellular responses to chronic
CS exposure that include oxidative stress, inflammation, lung cell injury
that results in cell death and tissue remodeling, as well as neoplasia
[36]. In particular, in pulmonary emphysema, which is primarily caused
by chronic CS, excessive ceramide production has been a major
contributor to the apoptotic loss of lung endothelial cells that partici-
pate in gas exchange [19]. CS exposure in mice increased ceramide
production in other organs, including cardiomyocytes, leading to dis-
rupted cardiomyocyte mitochondrial function [20], and the skeletal
muscle [37]. In addition to a local production of ceramides in various
tissues, typically as a result of CS-induced oxidative stress [38] or
mitochondrial dysfunction [39], systemic ceramides are increased
during CS and can cause tissue damage. There are numerous studies
of how CS affects serum lipid profiles in general e most focusing on
cholesterol and associated lipoproteins, and how these are only
partially reversible upon smoking cessation [40]. Regarding ceramides
in particular, CS alone can result in the release of ceramide-rich
endothelial exosomes and microparticles into the systemic circula-
tion [41]. Profiling of metabolites in the serum of smokers and ex-
smokers indicated an accelerated production of ceramide in those
affected with chronic lung disease [42]. Furthermore, a study of former
smokers that also evaluated the impact of obesity and high-fat western
diet on plasma lipids, suggested that these were associated with
elevated levels of serum ceramides [43]. Thus islets could be indirectlyMOLECULAR METABOLISM 37 (2020) 100975  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.comaffected by CS-induced increases in circulating ceramides or by other
soluble components of CS that cross the alveolar-capillary lung barrier
and are distributed to tissues via the circulation [20,44]. Alternatively,
they could be injured by mediators released by other CS-activated cells
in a paracrine manner [28,29]. A third alternative is that CS-induced
changes in ceramide content arise via effects on multiple sphingoli-
pid metabolic pathways that participate in its synthesis, such as the de
novo pathway, sphingomyelin hydrolysis, activation of recycling
pathways, or inhibition of its catabolism/utilization towards smaller
sphingolipids and the synthesis of complex sphingolipids.
To determine the direct effects of CS on b-cells and isolated mouse
islets, we exposed them ex vivo to CSE and found that CSE markedly
decreased b-cell proliferation, viability, insulin biosynthesis, matura-
tion, and secretion. In parallel, ceramide levels were increased within
both CS-exposed islets and INS-1 b-cells. We next investigated
whether inhibition of ceramide synthesis could alter the effects of CS.
Results from these experiments were largely negative, suggesting that
upregulation of ceramide synthesis is not the main pathway respon-
sible for increased ceramide accumulation in response to CSE expo-
sure. In support of this, gene expression of key enzymes for ceramide
synthesis were decreased by CSE treatment in islets. Future studies of
sphingolipid metabolic flux will be needed to clarify fully the state of
ceramide metabolism in b-cells during all phases of smoking exposure
and cessation.
Nevertheless, multiple reports, recently reviewed by Boslem et al.
indicate that the accumulation of ceramide and other sphingolipids can
have a major impact on pancreatic b-cell function in both T1D and T2Dccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 9
Figure 8: CS impaired b-cell proliferation through cyclin D2 loss. (A) INS-1 cells were incubated with AC or CSE for 24 h and stained with propidium iodide (PI), and cell cycle
analysis was performed using flow cytometry. (B) Total RNA was isolated from treated INS-1 cells, and gene expression of a panel of cyclin genes was performed (Cyclin D1
(Ccnd1), D2 (Ccnd2), D3 (Ccnd3), A2 (Ccna2), E1 (Ccne1), G1 (Ccng1), Cdk2, Cdk4, Cdk6 were determined by qRT-PCR. (C) Total protein was isolated from treated cells and
immunoblotting was performed using antibodies against Cyclin D2 and actin. Results were normalized to actin levels. (D) Mouse islets were treated with 5% CSE for 24 h and qRT-
PCR of CyclinD2 was performed. (E) Immunostaining images of paraffin sections of pancreata from C57BL/6 J mouse treated with the combination of CS and HFD for 22 weeks.
(FeH) INS-1 cells were co-incubated with N-acetylcysteine (NAC: 5 mM) or the chemical chaperone TUDCA (TUD: 100 mM) and CSE for 24 h prior to assessment of gene or protein
expression. RNA was isolated from treated INS-1 cells and gene expression of potent cyclin-dependent kinase inhibitor p21(Cdkn1a) and cyclin genes (Ccnd2, Ccna2, Ccne1, Cdk4)
were determined by qRT-PCR (F and H). Cyclin D2 protein level was determined by immunoblotting (G); (I) Hypothesized pathway for oxidative stress-dependent cell cycle arrest in
b-cell. The numbers of replicates for each experiment are indicated by the open circles. Results are displayed as the means  S.E.M; *p < 0.05, **p < 0.01, ***p < 0.001
compared to AC treatment.
Original Article[45]. Sphingolipid metabolites, such as ceramide, sphingosine-1-
phosphate, and sphingomyelin, have been linked with activation of
oxidative and ER stress [45], b-cell apoptosis [46], disruption of
vesicle-trafficking [47], and inhibition of insulin gene expression [48].
Concurrently, many of these pathways are also reported to be involved
in smoking related toxicity in other cell types [18,19]. Indeed, gene
expression of both oxidative and ER stress markers were upregulated
in our in vitro model of smoke exposure, indicating a critical role for
these stress pathways in smoking related b-cell failure. Although prior
studies suggested the importance of ER stress in ceramide-induced
apoptosis and impaired b-cell function [45,49], our results demon-
strated that rescue of ER stress by the chemical chaperone TUDCA did
not mitigate the overall effects of CSE. In contrast, antioxidant treat-
ment with NAC markedly reduced CSE-induced apoptosis, normalized
expression of PC1/3 and Cyclin D2, and restored first phase insulin
secretion. Interestingly, NAC reduced CSE-induced ceramide accu-
mulation as well as ER stress, suggesting that oxidative stress could
play a determining role in ceramide signaling and the regulation of b-10 MOLECULAR METABOLISM 37 (2020) 100975  2020 The Authors. Published by Elsevier GmbH. Tcell apoptosis and dysfunction in response to CSE. A similar effect of
NAC on CSE-induced cell death was reported previously in lung
endothelial and epithelial cells [18,50]; however, our study is the first
to suggest that NAC may have beneficial effects on the b-cell in
smoking models. Tobacco smoke contains over 4000 noxious chem-
icals as well as free radicals and reactive oxygen species (ROS), with
many reported to show potential for biological oxidative damage due to
smoking [51,52]. In addition, it has also been reported that ceramide
accumulation can further increase oxidative stress [38], via several
mechanisms, including direct effects on the mitochondrial membrane
[53]. Thus, oxidative damage could be induced by free radicals and
ROS, which can be amplified when combined with ceramide accu-
mulation. Indeed, our data clearly demonstrated that CSE treatment led
to reduced mitochondrial function, including decreased respiration,
proton leak, and ATP production in INS-1 cells. These effects were
reversed by antioxidant treatment, suggesting an important mecha-
nistic involvement of the mitochondria in CS-induced b-cell toxicity.
Although further experimentation is needed, our data suggest ahis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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potential mutual, self-amplified interaction of ceramide and ROS in CS
induced-b-cell dysfunction.
The role of individual ceramide species in disease pathogenesis in
general and in diabetes is far from being fully elucidated. However, our
data is consistent with other reports in models of diabetes, where
ceramides with palmitoyl, behenic, and unsaturated lignoceroyl fatty
acids have been reported to be elevated in islets of streptozotocin-
treated rats [54]. Furthermore, in a study of mice fed an HFD, mice
deficient in the enzyme that metabolized sphingosine to S1P (SPhK1)
were more likely to develop diabetes associated with enhanced b-cell
apoptosis, further augmented by palmitic fatty acids, whereas S1P had
a pro-survival effect [55]. Although we did not measure S1P levels, the
further elevations in sphingosine and palmitoyl ceramide in CS-
exposed mice and islet cells are consistent with these results.
There are limitations to our study that should be considered. First, our
primary focus was to elucidate pathways associated with smoking
induced pancreatic b-cell dysfunction. Human physiological data has
shown that smoking also impacts insulin sensitivity. Indeed, we
observed evidence of worsened insulin resistance after smoking
cessation in our in vivo studies, but we did not explore mechanisms
associated with this finding. Our intent was to create an in vivo model
that fully recapitulated human responses to smoking. However, we did
not observe worsened glucose tolerance during the smoke exposure
period, likely due to the complexity of nicotine signaling on appetite
and energy expenditure. We overcame this limitation by coupling our
in vivo studies with an in vitro model of CSE-treatment in b-cells and
islets. Our study utilized male mice only, so we cannot extrapolate
these results to female animals.
Notwithstanding these limitations, our data identify several critical
mechanisms through which smoking impacts pancreatic b-cell func-
tion and survival. We found that smoking led to increased ceramide
content that was correlated with the activation of oxidative and
endoplasmic reticulum stress. At a mechanistic level, these changes
were associated with reduced insulin production, impaired insulin
processing, and reduced insulin secretion as well as reduced b-cell
viability and proliferation. Taken together, these data provide novel
insights into the mechanisms whereby cigarette smoking increases the
risk of T2D during both the smoking period and during the immediate
cessation period.
5. CONCLUSION
In summary, we conclude that CS exposure elevates the risk of
impaired glucose homeostasis through b-cell dysfunction caused by
oxidative stress and ceramide accumulation.
AUTHOR CONTRIBUTIONS
X.T. and Z.C. design of the study, data analysis and interpretation,
collection and assembly of data, and manuscript draft writing. C.L.,
R.N.B., S.K., J.M., P.S., S.A.W., and M.A.R. participated in data
collection and critical revision of the manuscript. I.P. contributed to
data analysis, provided critical reagents, and provided critical revision
of the manuscript. C.E.-M.: directed funding acquisition, study
conception and design, directed manuscript writing, and gave final
approval of the manuscript. T.K. directed funding acquisition,
conception and design of the study, data analysis and interpretation,
collection and assembly of data, and manuscript writing/editing. T.K.,
I.P., and C.E.-M. are the guarantors of this work, had full access to all
of the study data, and take responsibility for the integrity and accuracy
of the data.MOLECULAR METABOLISM 37 (2020) 100975  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.comFUNDING
This work was supported by Showalter young investigator award from
the Indiana University School of Medicine (to T.K.), National Institute of
Diabetes and Digestive and Kidney Diseases grants R01-DK-093954
and DK-104166 (to C.E.-M.), U.S. Department of Veterans Affairs Merit
Award I01BX001733 (to C.E.-M.), and gifts from the Sigma Beta So-
rority, the Ball Brothers Foundation, and the George and Frances Ball
Foundation (to C.E.-M.). X.T. was supported by the Diabetes and
Obesity DeVault Fellowship at the Indiana University School of Medi-
cine. R.N.B. was supported by NIH NIAID Training Grant (T32
AI060519) and a JDRF Postdoctoral Research Award (3-PDF-2017-
385-A-N). RO1HL077328 (to I. P.). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation
of the manuscript. The authors acknowledge the support of the Islet
and Physiology and Translation Cores of the Indiana Diabetes Research
Center (P30-DK-097512).
ACKNOWLEDGEMENT
The authors would like to thank Dr. Donalyn Scheuner (Indiana Bioscience Research
Institute) for her helpful advice and discussions. The authors would also like to thank
Dr. Evgeny Berdyshev (National Jewish Health) for his assistance with ceramide
analysis. We thank Dr. Kathleen Heidler, and Jacob Saliba (Indiana University), for
their technical support for in vivo smoke exposure experiments. We also thank Kara
Orr and Karishma Randhave (Indiana University) for their technical assistance.
CONFLICT OF INTEREST
No potential conflicts of interest relevant to this article were reported.
APPENDIX A. SUPPLEMENTARY DATA
Supplementary data to this article can be found online at https://doi.org/10.1016/j.
molmet.2020.100975.
REFERENCES
[1] Federation, I.D., 2015. IDF diabetes atlas, 7th ed. Belgium: Brussels.
[2] Spaulding, A.C., Eldridge, G.D., Chico, C.E., Morisseau, N., Drobeniuc, A., Fils-
Aime, R., et al., 2018. Smoking in correctional settings worldwide: prevalence,
bans, and interventions. Epidemiological Review, 82e95.
[3] Drope, J.S.N., Cahn, Z., Hamill, S., Islami, F., Liber, A., Nargis, N., et al., 2018.
Tobacco atlas, 6thEdition. American Cancer Society and Vital Strategies.
[4] Wang, Y., Ji, J., Liu, Y.J., Deng, X., He, Q.Q., 2013. Passive smoking and risk
of type 2 diabetes: a meta-analysis of prospective cohort studies. PloS One
8(7):e69915.
[5] Pan, A., Wang, Y., Talaei, M., Hu, F.B., Wu, T., 2015. Relation of active,
passive, and quitting smoking with incident type 2 diabetes: a systematic
review and meta-analysis. Lancet Diabetes Endocrinol 3(12):958e967.
[6] Willi, C., Bodenmann, P., Ghali, W.A., Faris, P.D., Cornuz, J., 2007. Active
smoking and the risk of type 2 diabetes: a systematic review and meta-
analysis. Journal of the American Medical Association 298(22):2654e2664.
[7] Athyros, V.G., Katsiki, N., Doumas, M., Karagiannis, A., Mikhailidis, D.P., 2013.
Effect of tobacco smoking and smoking cessation on plasma lipoproteins and
associated major cardiovascular risk factors: a narrative review. Current
Medical Research and Opinion 29(10):1263e1274.
[8] Godsland, I.F., Walton, C., 1992. Insulin resistance and cigarette smoking.
Lancet 340(8819):607.ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 11
Original Article[9] Fagard, R.H., Nilsson, P.M., 2009. Smoking and diabetes–the double health
hazard! Prim Care Diabetes 3(4):205e209.
[10] Arnson, Y., Shoenfeld, Y., Amital, H., 2010. Effects of tobacco smoke on
immunity, inflammation and autoimmunity. Journal of Autoimmunity 34(3):
J258eJ265.
[11] Wannamethee, S.G., Shaper, A.G., Perry, I.J., 2001. Smoking as a modifiable
risk factor for type 2 diabetes in middle-aged men. Diabetes Care 24(9):
1590e1595.
[12] Yeh, H.C., Duncan, B.B., Schmidt, M.I., Wang, N.Y., Brancati, F.L., 2010.
Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort
study. Annals of Internal Medicine 152(1):10e17.
[13] Hu, Y., Zong, G., Liu, G., Wang, M., Rosner, B., Pan, A., et al., 2018. Smoking
cessation, weight change, type 2 diabetes, and mortality. New England Journal
of Medicine 379(7):623e632.
[14] Su, Y., Han, W., Giraldo, C., De Li, Y., Block, E.R., 1998. Effect of cigarette
smoke extract on nitric oxide synthase in pulmonary artery endothelial cells.
American Journal of Respiratory Cell and Molecular Biology 19(5):819e825.
[15] Csordas, A., Kreutmayer, S., Ploner, C., Braun, P.R., Karlas, A., Backovic, A.,
et al., 2011. Cigarette smoke extract induces prolonged endoplasmic reticu-
lum stress and autophagic cell death in human umbilical vein endothelial cells.
Cardiovascular Research 92(1):141e148.
[16] Lemaitre, V., Dabo, A.J., D’Armiento, J., 2011. Cigarette smoke components
induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition
of mTOR signaling. Toxicological Sciences 123(2):542e549.
[17] Kunchithapautham, K., Atkinson, C., Rohrer, B., 2014. Smoke exposure
causes endoplasmic reticulum stress and lipid accumulation in retinal pigment
epithelium through oxidative stress and complement activation. Journal of
Biological Chemistry 289(21):14534e14546.
[18] Schweitzer, K.S., Hatoum, H., Brown, M.B., Gupta, M., Justice, M.J., Beteck, B.,
et al., 2011.Mechanisms of lung endothelial barrier disruption induced by cigarette
smoke: role of oxidative stress and ceramides. American Journal of Physiology -
Lung Cellular and Molecular Physiology 301(6):L836eL846.
[19] Petrache, I., Natarajan, V., Zhen, L., Medler, T.R., Richter, A.T., Cho, C., et al.,
2005. Ceramide upregulation causes pulmonary cell apoptosis and
emphysema-like disease in mice. Nature Medicine 11(5):491e498.
[20] Tippetts, T.S., Winden, D.R., Swensen, A.C., Nelson, M.B., Thatcher, M.O.,
Saito, R.R., et al., 2014. Cigarette smoke increases cardiomyocyte ceramide
accumulation and inhibits mitochondrial respiration. BMC Cardiovascular
Disorders 14:165.
[21] Teague, S.V., Pinkerton, K.E., Goldsmith, M., Gebremichael, A., Chang, S.,
Jenkins, R.A., et al., 2008. Sidestream cigarette smoke generation and
exposure system for environmental tobacco smoke studies. Inhalation Toxi-
cology 6(1):79e93.
[22] Tong, X., Kono, T., Anderson-Baucum, E.K., Yamamoto, W., Gilon, P., Lebeche, D.,
et al., 2016. SERCA2deficiency impairs pancreatic beta-cell function in response to
diet-induced obesity. Diabetes 65(10):3039e3052.
[23] Sims, E.K., Hatanaka, M., Morris, D.L., Tersey, S.A., Kono, T., Chaudry, Z.Z.,
et al., 2013. Divergent compensatory responses to high-fat diet between
C57BL6/J and C57BLKS/J inbred mouse strains. American Journal of Physi-
ology. Endocrinology and Metabolism 305(12):E1495eE1511.
[24] Jetton, T.L., Lausier, J., LaRock, K., Trotman, W.E., Larmie, B., Habibovic, A.,
et al., 2005. Mechanisms of compensatory beta-cell growth in insulin-resistant
rats: roles of Akt kinase. Diabetes 54(8):2294e2304.
[25] Kono, T., Ahn, G., Moss, D.R., Gann, L., Zarain-Herzberg, A., Nishiki, Y., et al.,
2012. PPAR-gamma activation restores pancreatic islet SERCA2 levels and
prevents beta-cell dysfunction under conditions of hyperglycemic and cytokine
stress. Molecular Endocrinology 26(2):257e271.
[26] Kono, T., Tong, X., Taleb, S., Bone, R.N., Iida, H., Lee, C.C., et al., 2018.
Impaired store-operated calcium entry and STIM1 loss lead to reduced insulin
secretion and increased endoplasmic reticulum stress in the diabetic beta-cell.
Diabetes 67(11):2293e2304.12 MOLECULAR METABOLISM 37 (2020) 100975  2020 The Authors. Published by Elsevier GmbH. T[27] Wang, C.Y., Liao, J.K., 2012. A mouse model of diet-induced obesity and
insulin resistance. Methods in Molecular Biology 821:421e433.
[28] Sliwinska-Mosson, M., Milnerowicz, H., Milnerowicz, S., Nowak, M.,
Rabczynski, J., 2012. Immunohistochemical localization of somatostatin and
pancreatic polypeptide in smokers with chronic pancreatitis. Acta Histoche-
mica 114(5):495e502.
[29] Caicedo, A., 2013. Paracrine and autocrine interactions in the human islet: more
than meets the eye. Seminars in Cell & Developmental Biology 24(1):11e21.
[30] Hoshino, A., Kowalska, D., Jean, F., Lazure, C., Lindberg, I., 2011. Modulation
of PC1/3 activity by self-interaction and substrate binding. Endocrinology
152(4):1402e1411.
[31] Szulc, Z.M., Bai, A., Bielawski, J., Mayroo, N., Miller, D.E., Gracz, H., et al.,
2010. Synthesis, NMR characterization and divergent biological actions of 2’-
hydroxy-ceramide/dihydroceramide stereoisomers in MCF7 cells. Bioorganic &
Medicinal Chemistry 18(21):7565e7579.
[32] Bhattacharjee, A., Prasad, S.K., Banerjee, O., Singh, S., Banerjee, A., Bose, A.,
et al., 2018. Targeting mitochondria with folic acid and vitamin B12 amelio-
rates nicotine mediated islet cell dysfunction. Environmental Toxicology 33(9):
988e1000.
[33] Kaneto, H., Kajimoto, Y., Fujitani, Y., Matsuoka, T., Sakamoto, K.,
Matsuhisa, M., et al., 1999. Oxidative stress induces p21 expression in
pancreatic islet cells: possible implication in beta-cell dysfunction. Dia-
betologia 42(9):1093e1097.
[34] Choi, D.-W., Jeon, J., Lee, A.S., Han, K.-T., Park, E.-C., Jang, S.-I., 2018.
Association between smoking behavior patterns and glycated hemoglobin
levels in a general population. International Journal of Environmental Research
and Public Health 15(10).
[35] Jee, S.H., Foong, A.W., Hur, N.W., Samet, J.M., 2010. Smoking and risk for
diabetes incidence and mortality in Korean men and women. Diabetes Care
33(12):2567e2572.
[36] Tuder, R.M., Petrache, I., 2012. Pathogenesis of chronic obstructive pulmonary
disease. Journal of Clinical Investigation 122(8):2749e2755.
[37] Thatcher, M.O., Tippetts, T.S., Nelson, M.B., Swensen, A.C., Winden, D.R.,
Hansen, M.E., et al., 2014. Ceramides mediate cigarette smoke-induced
metabolic disruption in mice. American Journal of Physiology. Endocrinology
and Metabolism 307(10):E919eE927.
[38] Petrache, I., Medler, T.R., Richter, A.T., Kamocki, K., Chukwueke, U., Zhen, L.,
et al., 2008. Superoxide dismutase protects against apoptosis and alveolar
enlargement induced by ceramide. American Journal of Physiology - Lung
Cellular and Molecular Physiology 295(1):L44eL53.
[39] Mizumura, K., Justice, M.J., Schweitzer, K.S., Krishnan, S., Bronova, I.,
Berdyshev, E.V., et al., 2018. Sphingolipid regulation of lung epithelial cell
mitophagy and necroptosis during cigarette smoke exposure. The FASEB
Journal 32(4):1880e1890.
[40] Maeda, K., Noguchi, Y., Fukui, T., 2003. The effects of cessation from ciga-
rette smoking on the lipid and lipoprotein profiles: a meta-analysis. Preventive
Medicine 37(4):283e290.
[41] Serban, K.A., Rezania, S., Petrusca, D.N., Poirier, C., Cao, D., Justice, M.J.,
et al., 2016. Structural and functional characterization of endothelial micro-
particles released by cigarette smoke. Scientific Reports 6:31596.
[42] Bowler, R.P., Jacobson, S., Cruickshank, C., Hughes, G.J., Siska, C., Ory, D.S.,
et al., 2015. Plasma sphingolipids associated with chronic obstructive pul-
monary disease phenotypes. American Journal of Respiratory and Critical Care
Medicine 191(3):275e284.
[43] Drazba, A.M., Holásková, I., Sahyoun, R.N., Ventura Marra, M., 2019. Asso-
ciations of adiposity and diet quality with serum ceramides in middle-aged
adults with cardiovascular risk factors. Journal of Clinical Medicine 8(4).
[44] Levy, M., Khan, E., Careaga, M., Goldkorn, T., 2009. Neutral sphingomyelinase
2 is activated by cigarette smoke to augment ceramide-induced apoptosis in
lung cell death. American Journal of Physiology - Lung Cellular and Molecular
Physiology 297(1):L125eL133.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
www.molecularmetabolism.com
[45] Boslem, E., Meikle, P.J., Biden, T.J., 2012. Roles of ceramide and sphingo-
lipids in pancreatic beta-cell function and dysfunction. Islets 4(3):177e187.
[46] Veluthakal, R., Palanivel, R., Zhao, Y., McDonald, P., Gruber, S., Kowluru, A.,
2005. Ceramide induces mitochondrial abnormalities in insulin-secreting INS-
1 cells: potential mechanisms underlying ceramide-mediated metabolic
dysfunction of the b cell. Apoptosis 10(4):841e850.
[47] Gjoni, E., Brioschi, L., Cinque, A., Coant, N., Islam, M.N., Ng, C.K., et al., 2014.
Glucolipotoxicity impairs ceramide flow from the endoplasmic reticulum to the
Golgi apparatus in INS-1 beta-cells. PloS One 9(10):e110875.
[48] Kelpe, C.L., Moore, P.C., Parazzoli, S.D., Wicksteed, B., Rhodes, C.J.,
Poitout, V., 2003. Palmitate inhibition of insulin gene expression is mediated at
the transcriptional level via ceramide synthesis. Journal of Biological Chemistry
278(32):30015e30021.
[49] Lei, X., Zhang, S., Emani, B., Barbour, S.E., Ramanadham, S., 2010. A link
between endoplasmic reticulum stress-induced beta-cell apoptosis and the
group VIA Ca2þ-independent phospholipase A2 (iPLA2beta). Diabetes, Obesity
and Metabolism 12(Suppl 2):93e98.
[50] Kosmider, B., Messier, E.M., Chu, H.W., Mason, R.J., 2011. Human
alveolar epithelial cell injury induced by cigarette smoke. PloS One 6(12):
e26059.MOLECULAR METABOLISM 37 (2020) 100975  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.com[51] Valavanidis, A., Vlachogianni, T., Fiotakis, K., 2009. Tobacco smoke:
involvement of reactive oxygen species and stable free radicals in mechanisms
of oxidative damage, carcinogenesis and synergistic effects with other
respirable particles. International Journal of Environmental Research and
Public Health 6(2):445e462.
[52] Isik, B., Ceylan, A., Isik, R., 2007. Oxidative stress in smokers and non-
smokers. Inhalation Toxicology 19(9):767e769.
[53] García-Ruiz, C., Colell, A., Marí, M., Morales, A., Fernández-Checa, J.C., 1997.
Direct effect of ceramide on the mitochondrial electron transport chain leads to
generation of reactive oxygen species: role OF mitochondrial glutathione.
Journal of Biological Chemistry 272(17):11369e11377.
[54] Fox, T.E., Bewley, M.C., Unrath, K.A., Pedersen, M.M., Anderson, R.E.,
Jung, D.Y., et al., 2011. Circulating sphingolipid biomarkers in models of type
1 diabetes. The Journal of Lipid Research 52(3):509e517.
[55] Qi, Y., Chen, J., Lay, A., Don, A., Vadas, M., Xia, P., 2013. Loss of sphin-
gosine kinase 1 predisposes to the onset of diabetes via promoting
pancreatic beta-cell death in diet-induced obese mice. The FASEB Journal
27(10):4294e4304.ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 13
